legal settlement | GenomeWeb

legal settlement

Illumina follows Agilent, Life Technologies, Affymetrix, Siemens, and Luminex in settling lawsuits alleging infringement of US Patent No 7,064,197.

Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.

Affymetrix will pay Enzo $10 million to settle litigation Enzo brought against the company over a method for nucleic acid analysis.

Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.

The deal comes after a California Superior Court found no fraudulent intent on the part of the company.

The companies had been involved in a years-long legal battle over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's human metapneumovirus IP.

The preliminary approval is the penultimate step to bringing to a close a class action lawsuit accusing Celera of making false and misleading statements about its finances.

A few more lawsuits related to Myriad Genetics' hereditary cancer testing patents are now put to bed. 

The parties have decided to drop their claims and counterclaims against eachother ending a patent infringement lawsuit on BRCA testing.

The deal brings an end to a dispute going back to 2010 between the two firms.

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.